• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Integrated omics and computational glycobiology reveal structural basis for Influenza A virus glycan microheterogeneity and host interactions

tetano

Editor, Senior Moderator
Mol Cell Proteomics. 2016 Mar 16. pii: mcp.M116.058016. [Epub ahead of print]
[h=1]Integrated omics and computational glycobiology reveal structural basis for Influenza A virus glycan microheterogeneity and host interactions.[/h] Khatri K[SUP]1[/SUP], Klein JA[SUP]1[/SUP], White MR[SUP]1[/SUP], Grant OC[SUP]2[/SUP], Leymarie N[SUP]1[/SUP], Woods RJ[SUP]2[/SUP], Hartshorn KL[SUP]1[/SUP], Zaia J[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Despite sustained biomedical research effort, influenza A virus remains an imminent threat to the world population and a major healthcare burden. The challenge in developing vaccines against influenza is the ability of the virus to mutate rapidly in response to selective immune pressure. Hemagglutinin is the predominant surface glycoprotein and the primary determinant of antigenicity, virulence and zoonotic potential. Mutations leading to changes in the number of HA glycosylation sites are often reported. Such genetic sequencing studies predict at best the disruption or creation of sequons for N-linked glycosylation; they do not reflect actual phenotypic changes in HA structure. Therefore, combined analysis of glycan micro- and macro-heterogeneity and bioassays will better define the relationships among glycosylation, viral bioactivity and evolution. We present a study that integrates proteomics, glycomics and glycoproteomics of HA before and after adaptation to innate immune system pressure. We combined this information with glycan array and immune lectin binding data to correlate the phenotypic changes with biological activity. Underprocessed glycoforms predominated at the glycosylation sites found to be involved in viral evolution in response to selection pressures and interactions with innate immune-lectins. To understand the structural basis for site-specific glycan microheterogeneity at these sites, we performed structural modeling and molecular dynamics simulations. We observed that the presence of immature, high-mannose type glycans at a particular site correlated with reduced accessibility to glycan remodeling enzymes. Further, the high mannose glycans at sites implicated in immune lectin recognition were predicted to be capable of forming trimeric interactions with the immune-lectin surfactant protein-D.
Copyright ? 2016, The American Society for Biochemistry and Molecular Biology.


[h=4]KEYWORDS:[/h] Glycoprotein Structure*; Glycoproteomics; Glycosylation; Infectious disease; Mass Spectrometry; Viruses

PMID: 26984886 [PubMed - as supplied by publisher] Free full text
 
Back
Top Bottom